路透6月26日 - 兰特斯控股公司（Lantheus Holdings）周五表示，美国食品和药物管理局（FDA）以第三方生产设施存在尚未解决的生产相关问题为由，拒绝批准该公司用于检测多种癌症肿瘤的 LNTH.O 诊断成像试剂盒。
路透6月26日 - 兰特斯控股公司（Lantheus Holdings）周五表示，美国食品和药物管理局（FDA）以第三方生产设施存在尚未解决的生产相关问题为由，拒绝批准该公司用于检测多种癌症肿瘤的 LNTH.O 诊断成像试剂盒。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.